{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:35:31Z","timestamp":1761863731118,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":392,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jcin.2017.06.014","type":"journal-article","created":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T14:22:55Z","timestamp":1503325375000},"page":"1659-1661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor"],"prefix":"10.1016","volume":"10","author":[{"given":"Udaya S.","family":"Tantry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Hoon","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Gurbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2017.06.014_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.06.014_bib2","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.06.014_bib3","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.116.024710","article-title":"The dogged search for cryptic effects of ticagrelor: wishful thinking or real benefits beyond P2Y12 inhibition?","volume":"134","author":"Gurbel","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.06.014_bib4","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/ATVBAHA.114.304002","article-title":"Chronic treatment with ticagrelor limits myocardial infarct size: an adenosine and cyclooxygenase-2-dependent effect","volume":"34","author":"Nanhwan","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2017.06.014_bib5","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/CIRCULATIONAHA.116.024014","article-title":"Protective effects of ticagrelor on myocardial injury after infarction","volume":"134","author":"Vilahur","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.06.014_bib6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/ATVBAHA.111.226845","article-title":"Regulation of neutrophil function by adenosine","volume":"32","author":"Barletta","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jcin.2017.06.014_bib7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/FJC.0b013e3182471d14","article-title":"Adenosine A\u2082A and A\u2083 receptors are involved in the human endothelial progenitor cells migration","volume":"59","author":"Fernandez","year":"2012","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.jcin.2017.06.014_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2015.03.414","article-title":"Ticagrelor increases endothelial progenitor cell level compared to clopidogrel in acute coronary syndromes: a prospective randomized study","volume":"187","author":"Bonello","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2017.06.014_bib9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.jacc.2016.02.023","article-title":"Ticagrelor improves peripheral arterial function in acute coronary syndrome patients: relationship with adenosine plasma level","volume":"67","author":"Fromonot","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.06.014_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijcard.2017.04.108","article-title":"Effects of ticagrelor on neointimal hyperplasia and endothelial function, compared with clopidogrel and prasugrel, in a porcine coronary stent restenosis model","volume":"240","author":"Kim","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2017.06.014_bib11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jcin.2017.05.064","volume":"10","author":"Jeong","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2017.06.014_bib12","doi-asserted-by":"crossref","first-page":"478","DOI":"10.5414\/CP202017","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers","volume":"52","author":"Teng","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.jcin.2017.06.014_bib13","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1253\/circj.CJ-15-0270","article-title":"Comparison of prasugrel and ticagrelor antiplatelet effects in Korean patients presenting with ST-segment elevation myocardial infarction","volume":"79","author":"Lee","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jcin.2017.06.014_bib14","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jcin.2017.06.014_bib15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2016.04.087","article-title":"One-quarter standard-dose ticagrelor better than standard-dose clopidogrel in Chinese patients with stable coronary artery disease: a randomized, single-blind, crossover clinical study","volume":"215","author":"He","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2017.06.014_bib16","first-page":"38","article-title":"What is the \u201cEast Asian paradox\u201d?","volume":"1","author":"Jeong","year":"2012","journal-title":"Cardiosource Interventional News"},{"key":"10.1016\/j.jcin.2017.06.014_bib17","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1160\/TH16-10-0744","article-title":"Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: the REMODELING Trial","volume":"117","author":"Park","year":"2017","journal-title":"Thromb Haemost"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817312013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817312013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:05:43Z","timestamp":1761847543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879817312013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":17,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1936879817312013"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2017.06.014","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2017.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2017.05.064","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}